RE:RE:My take for what its worth.yes,
we now own 3 oncology clinics with revenues in the 10's of millions yearly.
Added that we now offer Aristotle to that mix. it is easy to see that the potential to make alot of money is there.
sprinkle on free covid testing revenue plus exposure. and we have a recipe for solid growth.
Be it, if you can handle the stress of the poor communication of Tripp.
I myself base my opinion on information provided in the MD&A and Financials and prospectus.
when you take all of that information, it is easy to see that this company is now poised to attack at full speed.
yes, it was a dramatic weekend, yes investor sentiment is at all time lows and trust in tripp is even lower.
but the risk is still worth the reward in my opinion as they are 4 times as strong for 1/4 of the price.
Cheers